AGENDA
AGENDA
| 12:00 – 15:30h | ALLIED HEALTH PROFESSIONALS PROGRAM- Cascade Ballroom |
| 12:00 – 12:15h | Welcome |
| 12:15 – 13:00h | Multiple Myeloma Adverse Events and Frailty Discussion – Beth Faiman |
| 13:00 – 13:45h | Creative Solutions to Workload Issues – A Novel Pharmacy Led Myeloma Therapy Clinic – Marina Ebied |
| 13:45 – 14:30h | COVID-19 Treatment in Patients with Lymphoproliferative Disorders – Alisha Shivji |
| 14:30 – 15:15h | Inclusion, Diversity, Equity & Accessibility (IDEA) in Oncology Patient Care – Frances Folkman |
| 15:15h | Concluding Remarks |
| 1600-1700h | Registration and CCOLD Welcome Reception- Riverview Lounge |
| 1700-1710h | CCOLD Opening Remarks – Dr. Wendy Lam and Dr. Laurie Sehn – Cascade Ballroom |
MYELOMA SESSION
| 1710-1715h | Welcome & Introductions – Chair: Dr. Wendy Lam |
| 1715-1735h | Role of MRD in Myeloma – Dr. Chris Venner |
| 1735-1755h | Management of Ultra-High Risk Myeloma – Dr. Chris Chen |
| 1755-1815h | Bispecific Antibodies for Myeloma- Dr. Darrell White |
| 1815-1835h | CART for Myeloma- Dr. Chris Venner |
| 1835-1855h | Front-line Treatment for Myeloma
Point: ASCT- Dr. Chris Chen |
| 1855-1920h | Panel Discussion – Chair: Dr. Wendy Lam, Panel: Dr. Venner, Dr. Chen, Dr. White, Dr. Sandhu |
| 1930h | CCOLD Opening Dinner – Alberta / New Brunswick Ballroom |
SATURDAY, MARCH, 25, 2023
| 0630-0700h | Breakfast – Riverview Room |
CLL SESSION
| 0700-0705h | Welcome and Introductions – Chair: Dr. Julie Stakiw – Cascade Ballroom |
| 0705-0735h | Treatment form Newly Diagnosed CLL – Dr. Matthew Davids |
| 0735-0805h | Treatment for Relapsed/Refractory CLL – Dr. Constantine Tam |
| 0805-0830h | The Value of MRD in Management of CLL in 2023 – Dr. Carolyn Owen |
| 0830-0900h | Richter’s Transformation in CLL – Dr. Matthew Davids |
| 0900-1000h | Panel Discussion – Chair: Dr. Julie Stakiw, Panel: Dr. Davids, Dr. Tam, Dr. Owen |
YOUNG INVESTIGATORS’ POSTER SESSION
| 1300-1645h | Reception – Young Investigators’ Poster and Oral Presentations – Riverview Room |
| 1645-1700h | Presentation Best Poster – Dr. Anca Prica |
LYMPHOMA SESSION
| 1700-1705h | Welcome and Introductions – Chair: Dr. Nathalie Johnson – Cascade Ballroom |
| 1705-1730h | Best of ASH – Dr. Laurie Sehn |
| 1730-1800h | The Promise of Bispecifics in B-cell NHL – Dr. Martin Hutchings |
| 1800-1830h | Waldenstroms Macroglobulinemia – Dr. Constantine Tam |
| 1830-1900h | Mantle Cell Lymphoma – Dr. Julie Vose |
| 1900h-1925h | Panel Discussion – Chair: Dr. Nathalie Johnson, Panel: Dr. Hutchings, Dr. Sehn, Dr. Tam, Dr. Vose |
| 1930h | Dinner – Alhambra Ballroom /Foyer |
SUNDAY MARCH 26, 2023
| 0630-0700h | Breakfast – Riverview Room |
LYMPHOMA SESSION
| 0700-0705h | Welcome and Introductions – Dr. Anca Prica – Cascade Ballroom |
| 0705-0730h | Lymphoma Classification Systems: What You Need to Know – Dr. Julie Vose |
| 0730-0800h | Relapsed Refractory DLBCL – Dr. Jeremy Abramson |
| 0800-0840h | Debate: |
| Bispecifics Should be 3rd Line Treatment for DLBCL –Dr. Martin Hutchings | |
| CART Should be 3rd Line Treatment for DLBCL- Dr. Jeremy Abramson | |
| 0840-0905h | Maintenance Therapy in B-cell Lymphomas: What to Keep, What to Abandon?- Dr. Diego Villa |
| 0905h-0955h | Panel Discussion: Chair: Dr. Anca Prica, Panel: Dr. Abramson, Dr. Hutchings, Dr. Vose, Dr. Villa |
| 0955-1000h | Closing Remarks- Dr. Laurie Sehn and Dr. Wendy Lam |